Thompson Siegel & Walmsley LLC Sarepta Therapeutics, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.43 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$765 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$673 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$644 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$321 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$302 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.49B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...